SK

Sumit Kedarnath Kabra

Active Director Director DIN 01218621
DIN 01218621 First appointment Sep 2000 Primary industry Pharma
Unlock full profile Investments · shareholding · contact details
Current companies 1 active board seats
Total affiliations 1 Since Sep 2000
Shareholding value •••• Premium profile

About Sumit Kedarnath Kabra

Data last updated:

Sumit Kedarnath Kabra is a Director at Polymed Pharmaceuticals Private Limited (since 2000). The company operates in Pharma. Polymed Pharmaceuticals Private Limited reported revenue of ₹2.52 Cr (FY 2025).

DIN 01218621
Primary Designation Director
Industry Pharma
First Appointment 29 Sep 2000
Oldest Company Age 52 yrs
Largest company Polymed Pharmaceuticals Private Limited · ₹2.52 Cr (FY 2025)

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Director29 Sep 20001974₹2.52 Cr (FY 2025)Active

Directorship timeline

Open interactive timeline →
Polymed Pharmaceuticals Private Limited
Premium access

Shareholding and investment profile for Sumit Kedarnath Kabra

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Sumit Kedarnath Kabra

Sumit Kedarnath Kabra currently holds 1 directorship: Polymed Pharmaceuticals Private Limited (Director, since 29 Sep 2000, revenue ₹2.52 Cr (FY 2025)).

Sumit Kedarnath Kabra was first appointed on 29 Sep 2000 as Director at Polymed Pharmaceuticals Private Limited.

The current boards of Sumit Kedarnath Kabra's companies include Kausalya Kedarnath Kabra (Polymed Pharmaceuticals Private Limited), Mamta Sunit Kabra (Polymed Pharmaceuticals Private Limited), Sunit Kedarnath Kabra (Polymed Pharmaceuticals Private Limited), Suvarna Sumit Kabra (Polymed Pharmaceuticals Private Limited).

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available